Header Logo

Mindy Simpson

Concepts (131)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemophilia A
18
2023
46
6.310
Why?
Factor VIII
13
2023
32
4.370
Why?
Coagulants
7
2020
11
3.070
Why?
Hemorrhage
9
2023
81
3.050
Why?
Polyethylene Glycols
2
2020
43
1.380
Why?
Antibodies, Neutralizing
4
2018
19
1.050
Why?
Isoantibodies
3
2018
8
1.000
Why?
Hemarthrosis
6
2021
20
0.960
Why?
Drug Substitution
1
2020
4
0.720
Why?
Recombinant Proteins
6
2020
213
0.640
Why?
Health Literacy
1
2021
109
0.640
Why?
Physicians
1
2020
124
0.600
Why?
Adolescent
10
2021
2307
0.570
Why?
Patient Satisfaction
1
2020
328
0.550
Why?
Drug Administration Schedule
4
2020
166
0.540
Why?
Child
8
2020
1421
0.540
Why?
Mutation
1
2018
353
0.520
Why?
Young Adult
9
2021
2069
0.460
Why?
Time Factors
5
2020
1490
0.450
Why?
Factor VIIa
3
2017
7
0.430
Why?
Hemophilia B
3
2017
10
0.430
Why?
Humans
25
2023
28408
0.420
Why?
Fibrinolysis
2
2013
7
0.390
Why?
Male
16
2021
15273
0.370
Why?
Genetic Predisposition to Disease
2
2018
390
0.370
Why?
United States
5
2020
2197
0.370
Why?
Fibrinolysin
1
2011
1
0.370
Why?
Thrombin
1
2011
15
0.370
Why?
Blood Coagulation
1
2011
20
0.370
Why?
Adult
9
2020
8097
0.320
Why?
Treatment Outcome
5
2020
3615
0.320
Why?
Retrospective Studies
4
2023
3609
0.300
Why?
Quality of Life
3
2020
659
0.270
Why?
Severity of Illness Index
3
2020
986
0.270
Why?
Middle Aged
7
2020
9254
0.260
Why?
Half-Life
3
2023
12
0.260
Why?
Child, Preschool
6
2017
689
0.260
Why?
Randomized Controlled Trials as Topic
3
2020
330
0.250
Why?
Surveys and Questionnaires
2
2021
1216
0.240
Why?
Risk Assessment
1
2017
676
0.230
Why?
Pilot Projects
2
2021
439
0.190
Why?
Phenotype
3
2018
311
0.180
Why?
Clinical Trials, Phase I as Topic
1
2020
7
0.180
Why?
Clinical Trials, Phase II as Topic
1
2020
21
0.180
Why?
Joint Diseases
2
2012
113
0.180
Why?
Israel
1
2020
17
0.170
Why?
Cardiac Surgical Procedures
1
2020
45
0.170
Why?
Netherlands
1
2020
25
0.170
Why?
Drug Costs
1
2020
13
0.170
Why?
Cost Savings
1
2020
36
0.170
Why?
Hodgkin Disease
1
2009
17
0.170
Why?
Fluorodeoxyglucose F18
1
2009
37
0.160
Why?
Positron-Emission Tomography
1
2009
89
0.160
Why?
Sickle Cell Trait
1
2018
2
0.150
Why?
Attitude of Health Personnel
1
2020
159
0.150
Why?
Television
1
2018
7
0.150
Why?
South America
1
2018
3
0.150
Why?
Asia
1
2018
10
0.150
Why?
Africa
1
2018
11
0.150
Why?
Information Dissemination
1
2018
20
0.150
Why?
Genetic Testing
1
2018
59
0.150
Why?
North America
1
2018
43
0.150
Why?
DNA Mutational Analysis
1
2018
59
0.150
Why?
Europe
1
2018
66
0.150
Why?
Sports Medicine
1
2018
37
0.150
Why?
Prothrombin
1
2017
4
0.150
Why?
Athletes
1
2018
88
0.140
Why?
Social Media
1
2018
50
0.140
Why?
Anticoagulants
2
2015
90
0.140
Why?
Risk Factors
2
2018
2408
0.140
Why?
Predictive Value of Tests
1
2018
492
0.130
Why?
von Willebrand Factor
1
2016
10
0.130
Why?
Hematology
1
2016
4
0.130
Why?
Physicians, Women
1
2016
17
0.130
Why?
Physician Executives
1
2016
8
0.130
Why?
Career Choice
1
2016
30
0.130
Why?
Blood Coagulation Tests
2
2016
11
0.130
Why?
Tomography, X-Ray Computed
1
2009
730
0.120
Why?
Leadership
1
2016
107
0.120
Why?
Venous Thrombosis
1
2015
46
0.120
Why?
Infant
3
2016
587
0.110
Why?
Lung Neoplasms
1
2009
553
0.110
Why?
Factor VII Deficiency
1
2013
1
0.110
Why?
Female
6
2020
15708
0.100
Why?
Factor IX
1
2012
7
0.100
Why?
Dose-Response Relationship, Drug
3
2017
351
0.100
Why?
Proportional Hazards Models
2
2016
352
0.090
Why?
Aged
3
2020
9262
0.090
Why?
Neoplasms, Germ Cell and Embryonal
1
2009
6
0.080
Why?
Death, Sudden
1
2009
7
0.080
Why?
Vena Cava, Inferior
1
2009
11
0.080
Why?
Constriction, Pathologic
1
2009
33
0.080
Why?
Testicular Neoplasms
1
2009
19
0.080
Why?
Headache
2
2017
34
0.070
Why?
Area Under Curve
2
2017
62
0.070
Why?
Survival Analysis
1
2017
267
0.070
Why?
Enzyme-Linked Immunosorbent Assay
1
2016
97
0.070
Why?
Patients
1
2023
35
0.050
Why?
Cohort Studies
1
2016
1926
0.050
Why?
Prospective Studies
2
2017
1805
0.040
Why?
Subtraction Technique
1
2009
1
0.040
Why?
Radiopharmaceuticals
1
2009
53
0.040
Why?
Newspapers as Topic
1
2018
1
0.040
Why?
Metabolic Clearance Rate
1
2017
6
0.040
Why?
Dizziness
1
2017
18
0.040
Why?
Cross-Over Studies
1
2017
63
0.040
Why?
Injections, Subcutaneous
1
2016
25
0.030
Why?
History, 21st Century
1
2016
24
0.030
Why?
History, 20th Century
1
2016
47
0.030
Why?
ROC Curve
1
2016
144
0.030
Why?
Drug Therapy, Combination
1
2016
183
0.030
Why?
Colorado
1
2015
4
0.030
Why?
Florida
1
2015
22
0.030
Why?
Endpoint Determination
1
2015
22
0.030
Why?
Single-Blind Method
1
2015
110
0.030
Why?
Observer Variation
1
2015
102
0.030
Why?
Quality Assurance, Health Care
1
2015
38
0.030
Why?
Diagnostic Imaging
1
2015
80
0.030
Why?
Feasibility Studies
1
2015
231
0.030
Why?
Recurrence
1
2015
322
0.030
Why?
Research Design
1
2015
207
0.030
Why?
Incidence
1
2016
773
0.030
Why?
Reproducibility of Results
1
2015
735
0.030
Why?
Synovitis
1
2011
21
0.020
Why?
Models, Molecular
1
2011
84
0.020
Why?
Cross-Sectional Studies
1
2013
932
0.020
Why?
Neoplasm Metastasis
1
2009
102
0.020
Why?
Vascular Diseases
1
2009
44
0.020
Why?
Autopsy
1
2009
343
0.020
Why?
Mice
1
2011
1461
0.020
Why?
Animals
1
2011
3780
0.010
Why?
Simpson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (131)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_